ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Indian-made COVID vaccines will save the world

China and US no match when it comes to manufacturing capacity and safety

| India
Vials of AstraZeneca's Covishield inside a lab at Serum Institute of India in Pune, pictured on Nov. 30: the COVID-19 vaccine is of particular value in developing nations.   © Reuters

Sreeram Chaulia is a professor and dean at the Jindal School of International Affairs in Sonipat, India. He is author of "Trumped: Emerging Powers in a Post-American World."

With vaccines from America's Pfizer and China's state-owned pharma group Sinopharm receiving their first overseas authorizations, the frantic race to produce and distribute the most-sought-after medicine in recent memory is on.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more